Targeted Oncology presents Case-Based Peer Perspectives. In each video, expert physicians provide insight on managing oncology-based patient cases that highlight the use of novel agents in clinical practice.
A 59-Year-Old Man With Extensive-Stage Small Cell Lung CancerJune 21st 2021
Thought leader in thoracic oncology, Hossein Borghaei, DO, reviews the case of a 59-year-old man with extensive-stage small-cell lung cancer and discusses the current treatment landscape by highlighting key clinical trial data on the safety and efficacy of lurbinectedin.
A 64-Year-Old Woman With Extensive-Stage Small Cell Lung CancerMay 18th 2021
Thought leader in thoracic oncology, Jared Weiss, MD, reviews the case of a 64-year-old woman with extensive-stage small-cell lung cancer and discusses the current treatment landscape by highlighting key clinical trial data on the safety and efficacy of lurbinectedin.
A 67-Year-Old Woman With Ovarian CancerApril 27th 2021
Chirag Shah, MD, MPH, an expert in gynecologic oncology, reviews the case of a 67-year-old woman with ovarian cancer and discusses factors to consider when selecting therapy including the recent results of the PRIMA and NOVA trials of niraparib in patients with ovarian cancer.
Expert Perspectives on a 75-Year-Old Woman With Triple-Class Refractory Multiple MyelomaApril 14th 2021
Adriana Rossi, MD, describes the treatment approach in caring for a 75-year-old woman with triple-class refractory multiple myeloma [RRMM] while highlighting results from the relevant DREAMM and SOHO studies.
A 75-Year-Old Man With Multiple MyelomaApril 7th 2021
A key opinion leader in hematology, Jonathan Kaufman, MD, provides insight into the case of a 75-year-old man with multiple myeloma and discusses treatment considerations, standard of care therapies, and recent clinical trial updates for the management of multiple myeloma.
A 72-Year-Old Man With Heavily Pretreated, Relapsed/Refractory Multiple MyelomaMarch 30th 2021
Sagar Lonial, MD, FACP, presents a case of a 72-year-old man with heavily pretreated relapsed/refractory multiple myeloma and discusses treatment options for patients with this diagnosis who have failed multiple prior lines of therapy.
A 50-Year-Old Woman With Steroid-Refractory Acute Graft Versus Host DiseaseMarch 12th 2021
Yi-Bin Chen, MD, reviews the case of a 50-year-old woman with steroid-refractory acute graft versus host disease (aGvHD) following allogeneic transplant and provides a discussion on treatment considerations for patients with aGvHD.